Diabetes Edinburgh

Oct 11, 2024 | onlinelibrary.wiley.com | Roland H. Stimson |Diabetes Edinburgh |Anna R Dover |Rohana J Wright

Despite substantial advances in diabetes care over the previous decade, only a minority of people with type 1 diabetes achieve an HbA1c <53 mmol/mol.1 Automated insulin delivery (AID) systems have consistently demonstrated efficacy in reducing HbA1c.2 Omnipod 5 (Insulet Corp) is a tubeless AID system which was launched in the United Kingdom in 2023. Here, we report the first 1-year CGM, HbA1c and weight outcomes in people using Omnipod 5, under routine clinical care, in the United Kingdom.

Oct 10, 2024 | dom-pubs.onlinelibrary.wiley.com | Anna R Dover |Rohana J Wright |Roland H. Stimson |Diabetes Edinburgh

1 BACKGROUND Most of the evidence supporting the efficacy of the Freestyle Libre system has accrued in people with type 1 diabetes.